National Average Inventory vs Dividend Yield Analysis
NHI Stock | USD 68.83 0.54 0.78% |
National Health financial indicator trend analysis is infinitely more than just investigating National Health Investors recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether National Health Investors is a good investment. Please check the relationship between National Health Average Inventory and its Dividend Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Average Inventory vs Dividend Yield
Average Inventory vs Dividend Yield Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of National Health Investors Average Inventory account and Dividend Yield. At this time, the significance of the direction appears to have weak relationship.
The correlation between National Health's Average Inventory and Dividend Yield is 0.35. Overlapping area represents the amount of variation of Average Inventory that can explain the historical movement of Dividend Yield in the same time period over historical financial statements of National Health Investors, assuming nothing else is changed. The correlation between historical values of National Health's Average Inventory and Dividend Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Average Inventory of National Health Investors are associated (or correlated) with its Dividend Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividend Yield has no effect on the direction of Average Inventory i.e., National Health's Average Inventory and Dividend Yield go up and down completely randomly.
Correlation Coefficient | 0.35 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Dividend Yield
Dividend Yield is National Health Investors dividend as a percentage of National Health stock price. National Health Investors dividend yield is a measure of National Health stock productivity, which can be interpreted as interest rate earned on an National Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Most indicators from National Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, National Health's Selling General Administrative is increasing as compared to previous years. The National Health's current Enterprise Value is estimated to increase to about 3.7 B, while Discontinued Operations is projected to decrease to under 16.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 287.1M | 268.4M | 308.3M | 169.0M | Total Revenue | 298.7M | 278.2M | 319.8M | 170.8M |
National Health fundamental ratios Correlations
Click cells to compare fundamentals
National Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.0B | 3.1B | 2.8B | 2.5B | 2.5B | 1.3B | |
Short Long Term Debt Total | 1.5B | 2.0B | 1.3B | 1.6B | 1.1B | 618.4M | |
Total Stockholder Equity | 1.5B | 1.5B | 1.5B | 1.3B | 1.3B | 729.6M | |
Net Debt | 1.4B | 1.5B | 1.2B | 1.1B | 1.1B | 1.2B | |
Retained Earnings | (5.3M) | (22.0M) | (84.6M) | (329.6M) | 2.5B | 2.6B | |
Non Currrent Assets Other | (308K) | 6.8M | 7.5M | 965K | 8.4M | 8.0M | |
Other Assets | 304.3M | 2.8B | 2.5B | 45.5M | 2.1B | 2.2B | |
Common Stock Shares Outstanding | 43.7M | 44.7M | 45.7M | 44.8M | 43.4M | 32.0M | |
Liabilities And Stockholders Equity | 3.0B | 3.1B | 2.8B | 2.5B | 2.5B | 1.3B | |
Non Current Liabilities Total | 1.5B | 1.5B | 1.3B | 1.1B | 1.1B | 559.3M | |
Other Stockholder Equity | 1.5B | 1.6B | 1.6B | 1.6B | (863.1M) | (819.9M) | |
Total Liab | 1.5B | 1.6B | 1.3B | 1.2B | 1.2B | 610.1M | |
Non Current Assets Total | 2.6B | 2.7B | 2.3B | 2.1B | 2.1B | 1.2B | |
Net Receivables | 429.4M | 390.7M | 399.4M | 315.0M | 330.0M | 238.6M | |
Total Current Assets | 463.5M | 437.1M | 505.2M | 379.8M | 352.3M | 256.7M | |
Other Current Liab | 45.6M | (408.6M) | (34.1M) | (376.4M) | 33.1M | 34.7M | |
Total Current Liabilities | 92.9M | 87.6M | 70.2M | 70.0M | 148.8M | 156.2M | |
Accounts Payable | 26.3M | 25.2M | 23.2M | 25.9M | 34.3M | 36.0M | |
Cash | 5.2M | 43.3M | 37.4M | 19.3M | 22.3M | 34.0M | |
Cash And Short Term Investments | 5.2M | 43.3M | 37.4M | 19.3M | 22.3M | 21.2M | |
Common Stock Total Equity | 446K | 452K | 459K | 434K | 499.1K | 351.3K | |
Accumulated Other Comprehensive Income | (3.4M) | (7.1M) | (84.6M) | (329.6M) | (350.2M) | (332.7M) | |
Common Stock | 446K | 452K | 459K | 434K | 499.1K | 355.8K | |
Short Term Debt | 1.2M | 458.4M | 75.4M | 415.4M | 75.4M | 63.4M | |
Other Liab | 30.4M | 23.3M | 14.6M | 5.1M | 4.5M | 4.3M | |
Long Term Debt | 1.4B | 1.5B | 1.2B | 1.1B | 1.1B | 663.6M | |
Current Deferred Revenue | 19.8M | 12.6M | 5.7M | 5.1M | 6.0M | 4.6M | |
Other Current Assets | (431.4M) | (431.5M) | (433.6M) | 45.5M | 7.3M | 7.6M | |
Net Tangible Assets | 1.5B | 1.5B | 1.5B | 1.3B | 1.5B | 1.2B | |
Capital Surpluse | 1.5B | 1.5B | 1.6B | 1.6B | 1.8B | 1.2B | |
Deferred Long Term Liab | 10.1M | 12.6M | 5.7M | 5.1M | 5.8M | 4.6M | |
Long Term Investments | 141.5M | 246.1M | 292.4M | 300.0M | 344.9M | 187.0M |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.